NCT00045994已完成2 期
Systolic and Pulse Pressure Hemodynamic Improvement By Restoring Elasticity: The SILVER Study
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 180
研究概览
简要总结
The purpose of this study is to evaluate the safety and efficacy of ALT-711 in the treatment of isolated systolic hypertension in a formal study in patients with left ventricular hypertrophy. Eligible patients will be randomized to double-blind treatment once daily for 6 months with oral ALT-711 (210 mg) or placebo.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
2 期
The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)HypertensionNCT00045981Synvista Therapeutics, Inc450
已完成
2 期
Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver MetastasesNeuroendocrine TumorsLiver MetastasesNCT03590119Marnix Lam26
已完成
3 期
Evaluate ALLN-177 in Patients With Enteric HyperoxaluriaEnteric HyperoxaluriaNCT03456830Allena Pharmaceuticals115
撤回
不适用
Treatment of Elevated Arterial Pulmonary Pressure With Inhaled IloprostPersistent Pulmonary HypertensionRespiratory Distress SyndromeNCT00216931Lund University Hospital40
Unknown
不适用
Effects of Intensive Systolic Blood Pressure Lowering Treatment on Out-of-office Blood Pressure - an Ancillary Study to Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) StudyBlood PressureNCT05352633China National Center for Cardiovascular Diseases710